“Marketing our products in Morocco is a natural progression for us,” said Heritage Chairman Jean-Claude Mas. “We are already well established in North Africa and the Middle East, with a distribution network in Turkey, Iran, Egypt, Lebanon, Israel, Tunisia, Kuwait and United Arab Emirates.”

He said the company has worked closely with Ikor-pharm, its Moroccan distributor, for the past year to plan for the distribution of the breast implants in Morocco, whose population is more than 30 million. Ikorpharm is the largest distributor of aesthetics, plastic and reconstructive products in that country.

“Morocco is yet another excellent market for our products,” Mas said. “They are popular with surgeons and patients in the region, and we estimate the annual Moroccan breast implant market to approximate 5,500 units, with double-digit increases.” He said that Heritage is “confident that the quality of our products, their leading aesthetics appearance and our alliance with this strong distributor will allow us to obtain at least 30% of this market within the next 12 months.”

Alain Serreyjol-Garros, CEO of the French company, said its international expansion “continues at a torrid pace. This is the third country in which we gained market approval within one month, [following] Brazil and Argentina.”

He added: “We are committed to increasing our worldwide market share, and we will do so country by country, surgeon by surgeon.” Heritage describes itself as “a top three global breast implant company.”

The company and its subsidiaries manufacture breast and other body implants and body support products worldwide. In addition to its headquarters and production facility in the Toulon metropolitan area in Southern France, it has a distribution facility in Spain.